Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTBP2 pseudogene 10 is a pseudogene in the human genome. Unlike protein-coding genes, pseudogenes do not produce functional proteins and generally do not serve as therapeutic targets. There is no evidence that CTBP2P10 is involved in biological regulation, disease processes, or drug interactions[5]. The canonical gene related to its name, CTBP2 (C-terminal binding protein 2), is a well-studied transcriptional corepressor and has known functions in gene regulation and cancer, but CTBP2P10 itself is distinct and non-functional as a protein-coding gene[1][2][5]. Key clarification: - CTBP2P10 is a pseudogene and not a therapeutic (drug, receptor, or enzyme) target. No biological, structural, or therapeutic information relevant to protein-coding targets applies to CTBP2P10[5]. - The biologically relevant protein is encoded by the gene CTBP2 (C-terminal binding protein 2), not by CTBP2P10. If you are seeking information on the functional protein target, refer instead to C-terminal binding protein 2 (CtBP2).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTBP2 pseudogene 10 (CTBP2P10).